Jeong-su Park
Teisen, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Cdc42 defect reveals insights into microvilli organization and function in T cell immunity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 25, 2025
UBE2N deficiency contributes to MASH development via p62-regulated mitophagy and PANoptosis.
Journal: Nature metabolism
Published: May 29, 2025
A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution.
Journal: Metabolism: clinical and experimental
Published: November 19, 2024
Blockade of 11β-hydroxysteroid dehydrogenase type 1 ameliorates metabolic dysfunction-associated steatotic liver disease and fibrosis.
Journal: Heliyon
Published: June 01, 2024
Korean Red Ginseng Improves Oxidative Stress-Induced Hepatic Insulin Resistance via Enhancing Mitophagy.
Journal: Foods (Basel, Switzerland)
Published: May 28, 2024
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis.
Journal: Experimental & molecular medicine
Published: March 14, 2024
Cocaine-derived hippuric acid activates mtDNA-STING signaling in alcoholic liver disease: Implications for alcohol and cocaine co-abuse.
Journal: Cell biology and toxicology
Published: February 28, 2024
Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway.
Journal: Biomolecules & therapeutics
Published: February 27, 2024
Zaluzanin C Alleviates Inflammation and Lipid Accumulation in Kupffer Cells and Hepatocytes by Regulating Mitochondrial ROS.
Journal: Molecules (Basel, Switzerland)
Published: October 09, 2023
The Roles of NFR2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases.
Journal: Antioxidants (Basel, Switzerland)
Published: September 28, 2023
Last Updated: 09/26/2026